This review assessed diagnostic performance of video capsule endoscopy for uncomplicated coeliac disease and found that it was not adequate to justify routine use as an alternative to small bowel biopsies. The authors suggested that video capsule endoscopy may be helpful where biopsy cannot be done and more studies are needed. These conclusions are appropriate to the limited data available.
Study selection
Prospective studies that assessed the diagnostic performance of video capsule endoscopy, in patients with symptoms of coeliac disease or biopsy proven coeliac disease, were eligible for inclusion. Included studies were required to use oesophagogastroduodenoscopy with duodenal pathology as the reference standard; the video capsule endoscopy reader had to be blinded to the results of duodenal pathology.
The primary outcome measure was successful diagnosis of coeliac disease using video capsule endoscopy. The secondary outcome measures were test-associated complications and costs of each diagnostic tool.
Two reviewers independently assessed studies for inclusion and disagreements were resolved by consensus.
Assessment of study quality
The methodological quality of included studies was assessed using the QUADAS (Quality Assessment of Diagnostic Accuracy Studies) tool, a 14 item checklist, which assessed aspects of internal validity (including verification biases, blinding, incorporation bias, review biases, disease progression bias, and handling of withdrawals and indeterminate test results) and generalisability.
Methodological quality was independently assessed by two reviewers; disagreements were resolved by consensus.
Data extraction
Data were extracted on diagnostic performance outcomes (sensitivity, specificity and positive and negative predictive values), complications (if any) and costs. Data were also extracted on endoscopic and video capsule endoscopy appearance, histological findings, and inter-observer/intra-observer variability.
Data were extracted by two reviewers, using a pre-formatted data extraction sheet.
Methods of synthesis
Overall sensitivity and specificity estimates, with 95% confidence intervals (CIs) were calculated using simple pooling (modified Wald approach) rather than meta-analysis. Likelihood ratios were estimated using the exact method for pooling common odds ratios; confidence intervals were calculated using the mid-P method.
Between study heterogeneity was assessed using the I 2 statistic.
Inter-observer and intra-observer agreement was assessed using the kappa statistic.
Results of the review
Three studies, with a total of 107 adult participants, were included in the review. All were prospective studies. No details of participant characteristics were reported. Two studies reported the time interval between oesophagogastroduodenoscopy and video capsule endoscopy; this ranged from one to 15 days, in most patients. The number of investigators performing video capsule endoscopy readings varied; one study used only one experienced gastroenterologist and the other two studies each used four investigators. For the two studies using multiple investigators, the kappa values were 0.26 to 1.0 and 0.56 to 0.87. The results of methodological quality assessment were not reported or discussed.
The pooled estimates for video capsule endoscopy in the diagnosing of coeliac disease were 83% (95% CI 71 to 90) for sensitivity and 98% (95% CI 88% to 99.6%) for specificity; there was no evidence of between study heterogeneity. The pooled estimate of positive likelihood ratio was 34.5 (95% CI 16.7 to 43.5) and negative likelihood ratio was 0.22 (95% CI 0.01 to 0.64), with no evidence of between study heterogeneity.
Only one study reported on complications; one patient with minor discomfort due to video capsule endoscopy, and eight patients with minor discomfort plus one patient with major discomfort due to oesophagogastroduodenoscopy.
Cost information
One study reported costs of £693 (UK pounds sterling) per patient for video capsule endoscopy and £410 per patient for oesophagogastroduodenoscopy.
